Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Oligodendroglioma 1Glioma 1Glioblastoma 1Brain Neoplasms 1Astrocytoma 1

Interventions

Temozolomide 4Flucytosine 4vocimagene amiretrorepvec 3vorasidenib 2trametinib 2paclitaxel-Angiopep-2 conjugate 2dabrafenib 2Surgical Procedures, Operative 2OKN 007 2Chlorotoxin 2Carmustine 2talampanel 1selinexor 1pemigatinib 1pembrolizumab 1olutasidenib 1motexafin gadolinium 1exatecan 1Vincristine 1Radiation 1PF-06840003 1ONC206 1O(6)-benzylguanine 1Metabolism 1IL13-PE38 1Genetic Therapy 1Genetic Engineering 1Filgrastim 1Fentanyl 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Oligodendroglioma × Metabolism × Clear all
NCT00591058 2009-07-17

Safety and Dose-Finding Study of TM-601 in Adults With Recurrent Malignant Glioma

TransMolecular

Phase 1 Unknown
36 enrolled
CNS

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Oligodendroglioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡